A COVID-19 vaccine for kids aged 12-15 could be approved for emergency use as early as next week, and children now account for 22% of new coronavirus cases in the U.S. Meanwhile, vaccine demand is down among adults. What to do about that?
Guest:
- Dr. Rhea Boyd, a Bay Area pediatrician and public health advocate
Loading transcript



